Self-microemulsifying drug delivery system (SMEDDS)-challenges and road ahead

Drug Delivery

Volumn 22, Issue 6, 2015, Pages 675-690

  Dokania, Shambhu ^a   Joshi, Amita K ^a  

^a B V PATEL PHARMACEUTICAL EDUCATION AND RESEARCH DEVELOPMENT PERD CENTRE   (India)

Author keywords

Lymphatic uptake; oxidation; polymorphism; precipitation inhibitors; self microemulsifying drug delivery system; solid SMEDDS; supersaturable SMEDDS

Indexed keywords

GELATIN; MEDIUM CHAIN TRIACYLGLYCEROL; OIL; SURFACTANT; UNSATURATED FATTY ACID; EMULSION; MICROCAPSULE; TRIACYLGLYCEROL;

CRYSTALLIZATION; DISPERSION; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SOLUBILITY; FIRST PASS EFFECT; HYDROGEN BOND; IN VITRO STUDY; LIPID OXIDATION; LIPOLYSIS; LIPOPHILICITY; MICROEMULSION; MICROENCAPSULATION; NANOEMULSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM; TEMPERATURE; BIOAVAILABILITY; CHEMISTRY; DRUG STABILITY; DRUG STORAGE; EMULSION; FOOD DRUG INTERACTION; INTESTINE ABSORPTION; MEDICINAL CHEMISTRY; MICROCAPSULE; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PHARMACEUTICS; PHARMACOKINETICS; PRECIPITATION; PROCEDURES; SOLUBILITY;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; CAPSULES; CHEMICAL PRECIPITATION; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG DELIVERY SYSTEMS; DRUG STABILITY; DRUG STORAGE; EMULSIONS; FOOD-DRUG INTERACTIONS; IN VITRO TECHNIQUES; INTESTINAL ABSORPTION; PARTICLE SIZE; SOLUBILITY; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL; TRIGLYCERIDES;

EID: 84941265553     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.896058     Document Type: Review

References (170)

1. Adesunloye TA, Stach PE. (1998). Effect of glycine/citric acid on the dissolution stability of hard gelatin capsules. Drug Dev Ind Pharm 24: 494-500
2. Agarwal V, Alayoubi A, Siddiqui A, Nazzal S. (2012). Powdered self-emulsified lipid formulations of meloxicam as solid dosage forms for oral administration. Drug Dev Ind Pharm 1-9
3. Ahn JH, Kim YP, Kim HS. (2012). Effect of natural antioxidants on the lipid oxidation of microencapsulated seed oil. Food Control 23: 528-54
4. Albert K, Bayer E, Worsching A, Vogele H. (1991). Investigation of the hardening reaction of gelatin with 13C labeled formaldehyde by solution and solid state 13C NMR spectroscopy. Z Naturforsch 46: 385-9
5. Alexandera JS, Gantaa VC, Jordanb PA, Witte MH. (2010). Gastrointestinal lymphatics in health and disease. Pathophysiology 17: 315-35
6. Anton N, Vandamme TF. (2010). Nano-emulsions and micro-emulsions: clarification of the critical differences. Pharm Res 28: 978-85
7. Amri A, Clanche SL, Thérond P, et al. (2013). Resveratrol self-emulsifying system increases the uptake by endothelial cells and improves protection against oxidative stress-mediated death. Eur J Pharm Biopharm : 10.1016/j.ejpb.2013.10.015. [Epub ahead of print]
8. Ash M. (2007). Handbook of pharmaceutical additives. New York: Synpase Information Resources, 30-2, 289, 481-2, 714-6
9. Avdeef A. (2003). Absorption and drug development solubility, permeability and charge state. New Jersey: Wiley-Interscience, 91-15
10. Azaz E, Donbrow M, Hamburger R. (1973). Incompatibility of non-ionic surfactants with oxidisable drugs. Pharm J 211: 15
11. Bansal T, Mustafa G, Khan ZI, et al. (2008). Solid self-nanoemulsifying delivery systems as a platform technology for formulation of poorly soluble drugs. Crit Rev Ther Drug Carrier Syst 25: 63-116
12. Barrett K, Brooks H, Boitano S, Barman S. (2009). Blood as a circulatory fluid & the dynamics of blood & lymph flow. Ganong's review of medical physiology. New York: McGraw Hill, 550-2
13. Barrio MD, Hu J, Zhou P, Cauchon N. (2006). Simultaneous determination of formic acid and formaldehyde in pharmaceutical excipients using headspace GC/MS. J Pharm Biomed Anal 41: 738-43
14. Bessho M, Kojima T, Okuda S, Hara M. (2007). Radiation-induced cross-linking of gelatin by using γ-rays: insoluble gelatin hydrogel formation. Bull Chem Soc Japan 80: 979-85
15. Bevernage J, Brouwers J, Brewster ME, Augustijns P. (2013). Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues. Int J Pharm 453: 25-35
16. Bindra DS, Williams TD, Stella VJ. (1994). Degradation of O6-benzylguanine in aqueous polyethylene glycol 400 (PEG 400) solutions: concerns with formaldehyde in PEG 400. Pharm Res 11: 1060-4
17. Bottom CB, Clark M, Carstensen JT. (1997). Dissolution testing of soft shell capsules-acetaminophen and nifedipine. J Pharm Sci 86: 1057-61
18. Boyd M, Risovic V, Jull P, et al. (2004). A stepwise surgical procedure to investigate the lymphatic transport of lipid based oral drug formulations: cannulation of the mesenteric and thoracic lymph ducts within the rat. J Pharmacol Toxicol Method 49: 115-20
19. Boyd BJ, Nguyen TH, Mullertz A. (2011). Lipids in oral controlled release drug delivery. In: Wilson CG., Crowley PJ, eds. Controlled release in oral drug delivery. New York: Springer, 299-321
20. Bowtle W. (2007). Materials, process, and manufacturing considerations for lipid-based hard-capsule formats. In: Hauss DJ, ed. Oral lipid-based formulations enhancing the bioavailability of poorly water-soluble drugs. vol. 170. New York: Informa Healthcare, 79-106
21. Brox W. (1988a). Gelatin capsule. US Patent 4,780,316
22. Brox W. (1988b). Soft gelatin capsules and methods for their production. US Patent 4,744,988
23. Cai S, Xie YM, Bagby TR, et al. (2008). Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate. J Surg Res 147: 247-52
24. Caliph SM, Charman WN, Porter CJH. (2000). Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph cannulated and non-cannulated rats. J Pharm Sci 89: 1073-84
25. Cao Y, Marra M, Anderson BD. (2004). Predictive relationships for the effects of triglyceride ester concentration and water uptake on solubility and partitioning of small molecules into lipid vehicles. J Pharm Sci 93: 2768-79
26. Chafetz L, Hong W, Tsilifonis DC, et al. (1984). Decrease in the rate of capsule dissolution due to formaldehyde from Polysorbate 80 autooxidation. J Pharm Sci 73: 1186-7
27. Charman WN, Noguchi T, Stella VJ. (1986). An experimental system designed to study the in situ intestinal lymphatic transport of lipophilic drugs in anesthetized rats. Int J Pharm 33: 155-64
28. Charman WN, Stella VJ. (1986). Estimating the maximal potentials for intestinal lymphatic transport of lipophilic drug molecules. Int J Pharm 34: 175-8
29. Chaw YFM, Crane LE, Lange P, Shapiro R. (1980). Isolation and identification of cross-links from formaldehyde-treated nucleic acids. Biochem 19: 5525-31
30. Chen ZQ, Liu Y, Zhao JH, et al. (2012). Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system. Int J Nanomed 7: 1115-25
31. Christensen KL, Pedersen GP, Kristensen, HG. (2001). Preparation of redispersible dry emulsions by spray drying. Int J Pharm 212: 187-94
32. Clement J. (2009). Intestinal absorption of triacylglycerols. Reprod Nutr Dev 20: 1285-307
33. Dahan A, Hoffman A. (2005). Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. Eur J Pharm Sci 24: 381-8
34. Dahan A, Hoffman A. (2007). The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex-vivo intestinal permeability data to predict in vivo bioavailability in rats. Eur J Pharm Biopharm 67: 96-105
35. Dahan A, Hoffman A. (2008). Rationalizing the selection of oral lipid based drug delivery system by an in vitro lipolysis model for improved oral bioavailability of poorly water soluble drugs. J Control Release 129: 1-10
36. Dai WG. (2010). In vitro methods to assess drug precipitation. Int J Pharm 393: 1-16
37. Davis P, Tabor BE. (1963). Kinetic study of the cross linking of gelatin by formaldehyde and glyoxal. J Polymer Sci 1: 799-815
38. Delalonde M, Ruiz T. (2008). Dissolution of pharmaceutical tablets: the influence of penetration and drainage of interstitial fluids. Chem Eng Process 47: 370-6
39. Digenis GA, Gold TB, Shah VP. (1994). Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J Pharm Sci 83: 915-21
40. Donbrow M, Azaz E, Pillersdorf A. (1978). Autoxidation of polysorbates. J Pharm Sci 67: 1676-81
41. Dressman JB, Amidon GL, Reppas C, Shah VP. (1998). Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm Res 15: 11-22
42. Dressman JB, Reppas C. (2000). In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur J Pharm Sci 11: S73-80
43. Driscoll CMO. (2002). Lipid-based formulations for intestinal lymphatic delivery. Eur J Pharm Sci 15: 405-15
44. Eccleston GM. (2007). Emulsions and microemulsions. In: Swarbrick J, ed. Encyclopedia of pharmaceutical technology, vol. 3. New York: Informa Healthcare, 1548-65
45. Edwards GA, Porter CJH, Caliph SM, et al. (2001). Animal models for the study of intestinal lymphatic drug transport. Adv Drug Deliv Rev 50: 45-60
46. Fan H, Dash AK. (2001). Effect of cross-linking on the in vitro release kinetics of doxorubicin from gelatin implants. Int J Pharm 213: 103-16
47. Fatouros DG, Mullertz A. (2008). In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability. Expert Opin Drug Metab Toxicol 4: 65-76
48. Frontini R, Mielck JB. (1995). Formation of formaldehyde in polyethylene glycol and in poloxamer under stress conditions. Int J Pharm 114: 121-3
49. Gao P. (2011). Design and development of self-emulsifying lipid formulations for improving oral bioavailability of poorly water-soluble and lipophilic drugs. In: Williams RO., Watts AB., Miller DA, eds. Formulating poorly water soluble drugs. New York: Springer, 243-66
50. Gao P, Morozowich W. (2006). Development of supersaturable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv 3: 97-110
51. Gao P, Rush BD, Pfund WP. (2003). Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci 92: 2386-98
52. Gao P, Morozowich W. (2007). Design and development of supersaturable self-emulsifying drug delivery systems for enhancing the gastrointestinal absorption of poorly soluble drugs. In: Hauss DJ, ed. Oral lipid-based formulations enhancing the bioavailability of poorly water-soluble drugs, vol. 170. New York: Informa Healthcare, 303-24
53. Gao P, Morozowich W. (2009). Improving the oral absorption of poorly soluble drug using SEDDS and S-SEDDS formulations. In: Qiu Y., Chen Y., Zhang GGZ, eds. Developing solid oral dosage forms theory and practice. New York: Academic Press, 443-9
54. Gao P, Shi Y. (2012). Characterization of supersaturable formulations for improved absorption of poorly soluble drug. AAPS Pharm Sci Tech 14: 703-13
55. Gold TB, Buice RG, Lodder RA, Digenis GA. (1998). Detection of formaldehyde-induced crosslinking in soft elastic gelatin capsules using near-infrared spectrophotometry. Pharm Dev Technol 3: 209-14
56. Gullapalli PR. (2010). Soft gelatin capsules (Softgels). J Pharm Sci 99: 4107-48
57. Ha E, Wang W, Wang YJ. (2002). Peroxide formation in polysorbate 80 and protein stability. J Pharm Sci 91: 2252-64
58. Hafez IM, Cullis PR. (2001). Roles of lipid polymorphism in intracellular delivery. Adv Drug Deliv Rev 47: 139-48
59. Hamburger R, Azaz E, Donbrow M. (1975). Autoxidation of polyoxyethylenic non-ionic surfactants and of polyethylene glycols. Pharm Acta Helv 50: 10-7
60. Hasebroock KM, Serkova NJ. (2009) Toxicity of MRI and CT contrast agents. Expert Opin Drug Met 5: 403-16
61. Hauer B, Meinzer A, Posanski U, Richter F. (1994). Pharmaceutical compositions comprising cyclosporins. US Patent 5,342,625
62. Hauer B, Meinzer A, Posanski U, Richter F. (2007). Pharmaceutical compositions comprising cyclosporins. US Patent 7,235,248
63. Hauser H, Poupart G. (1992). The structure of biological membranes. In: Yeagle PL, ed. The structure of biological membranes. Boca Raton: CRC Press, 3-21
64. Hauss DJ. (2007). Oral lipid-based formulations. Adv Drug Deliv Rev 59: 667-76
65. Hauss DJ, Mehta SC, Radebaugh GW. (1994). Targeted lymphatic transport and modified systemic distribution of CI-976, a lipophilic lipid regulator drug, via a formulation approach. Int J Pharm 108: 85-93
66. Hentzschel CM, Alnaief M, Smirnova I, et al. (2012). Tabletting properties of silica aerogel and other silicates. Drug Dev Ind Pharm 38: 462-7
67. Hoener BA, Benet LZ. (2002). Factors influencing drug absorption and drug availability. Drugs Pharm Sci 121: 93-117
68. Horter D, Dressman JB. (2001). Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev 46: 75-87
69. Huang Y, Tian R, Hu W, et al. (2012). A novel plug-controlled colon-specific pulsatile capsule with tablet of curcumin-loaded SMEDDS. Carbohydr Polym 92: 2218-23
70. Hu X, Lin C, Chen D, et al. (2012). Sirolimus solid self-microemulsifying pellets: formulation development, characterization and bioavailability evaluation. Int J Pharm 438: 123-33
71. Huang H, Solomon MS, Hopkins PB. (1992). Formaldehyde preferentially interstrand cross-links duplex DNA through deoxyadenosine residues at the sequence 50-d (AT). J Am Chem Soc 114: 9240-1
72. Humberstone AJ, Charman WN. (1997). Lipid-based vehicles for the oral delivery of poorly water soluble drugs. Adv Drug Deliv Rev 25: 103-28
73. Ito Y, Kusawake T, Ishida M, et al. (2005). Oral solid gentamicin preparation using emulsifier and adsorbent. J Control Release 105: 23-31
74. Janga KY, Jukanti R, Sunkavalli S, et al. (2012). In-situ absorption and relative bioavailability studies of Zaleplon loaded self-nanoemulsifying powders. J Microencapsul 30: 161-72
75. Jannin V, Musakhanian J, Marchaud D. (2008). Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev 60: 734-46
76. Johnson DM, Taylor WF. (1984). Degradation of fenprostalene in Polyethylene glycol 400 solution. J Pharm Sci 73: 1414-7
77. Kallakunta VR, Bandari S, Jukanti R, Veerareddy PR. (2012). Oral self emulsifying powder of lercanidipine hydrochloride: formulation and evaluation. Powder Technol 221: 375-82
78. Kang JH, Oh DH, Oh YK., (2012). Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self nanoemulsifying drug delivery system (solid SNEDDS). Eur J Pharm Biopharm 80: 289-97
79. Kashchiev D, Van Rosmalen GM. (2003). Nucleation in solutions revisited. Crystal Res Technol 38: 555-74
80. Khan AW, Kotta S, Ansari SH, et al. (2012). Potentials and challenges in self-nanoemulsifying drug delivery systems. Expert Opin Drug Deliv 9: 1305-17
81. Khoo SM, Humberstone AJ, Porter CJH, et al. (1998). Formulation design and bioavailability assessment of lipidic self emulsifying formulations of halofantrine. Int J Pharm 167: 155-64
82. Kohli K, Chopra S, Dhar D, et al. (2010). Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability. Drug Discov Today 15: 958-65
83. Kumar V, Kalonia DS. (2006). Removal of peroxides in polyethylene glycols by vacuum drying: implications in the stability of biotech and pharmaceutical formulations. AAPS PharmSciTech 7: E47-53
84. Ku MS, Li W, Dulin W, et al. (2010). Performance qualification of a new hypromellose capsule: Part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus®, QualiV® and gelatin capsules. Int J Pharm 386: 30-41
85. Laguerre M, Lecomte J, Villeneuve P. (2007). Evaluation of the ability of antioxidants to counteract lipid oxidation: existing methods, new trends and challenges. Prog Lipid Res 46: 244-82
86. Land LM, Li P, Bummer PM. (2005). The influence of water content of triglyceride oils on the solubility of steroids. Pharm Res 22: 784-8
87. Lawrence MJ, Warisnoicharoen W. (2006). Recent advances in microemulsions as drug delivery vehicles. In: Torchilin VP, ed. Nanoparticulates as drug carriers. London: Imperial College Press, 125-60
88. Li Z, Kozlowski BM, Chang EP. (2007). Analysis of aldehydes in excipients used in liquid/semi-solid formulations by gas chromatography-negative chemical ionization mass spectrometry. J Chromatogr A 1160: 299-305
89. Liang HC, Chang WH, Liang HF. (2004). Crosslinking structures of gelatin hydrogels crosslinked with genipin or a water-soluble carbodiimide. J Appl Polymer Sci 91: 4017-26
90. Mahmoud EA, Bendas ER, Mohamed MI. (2009). Preparation and evaluation of self-nanoemulsifying tablets of carvedilol. AAPS PharmSciTech 10: 183-92
91. Mathews C, Sugano K. (2010). Supersaturable formulations. Drug Deliv Sys 25-4: 371-4
92. McGinity JW, Hill JA, La Via AL. (1975). Influence of peroxide impurities in polyethylene glycols on drug stability. J Pharm Sci 64: 356-7
93. Mercuri A, Passalacqua A, Wickham MJW. (2011). The effect of composition and gastric conditions on the self-emulsification process of ibuprofen-loaded self-emulsifying drug delivery systems: a microscopic and dynamic gastric model study. Pharm Res 28: 1540-51
94. Milovic M, Djuris J. (2012). Characterization and evaluation of solid self microemulsifying drug delivery systems with porous carriers as systems for improved carbamazepine release. Int J Pharm 34: 1-8
95. Mohsin K. (2012). Design of lipid based formulations for oral administration for administration of poorly water-soluble drug fenofibrate: effects of digestion. AAPS PharmSciTech 13: 637-46
96. Mohsin K, Long MA, Pouton CW. (2008). Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. J Pharm Sci 98: 3582-95
97. Moreton RC, Armstrong NA. (1995). Design and use of an apparatus for measuring diffusion through glycerogelatin films. Int J Pharm 122: 79-89
98. Moreton RC, Armstrong NA. (1998). The effect of film composition on the diffusion of ethanol through soft gelatin films. Int J Pharm 161: 123-31
99. Müllertz A, Ogbonnaa A, Ren S, Rades T. (2010). New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs. J Pharm Pharmcol 62: 1622-36
100. Mu H, Holm R, Mullertz A. (2013). Lipid-based formulations of oral administration of poorly water-soluble drugs. Int J Pharm 453: 215-24
101. Mullin JW. (2001). Nucleation. In: Crystallization. 4 ed. London: Butterworth-Heinemann, 181-215
102. Myers RA, Stella VJ. (1992). Factors affecting the lymphatic transport of penclomedine (NSC-338720), a lypophilic cytotoxic drug: comparison to DDT and hexachlorobenzene. Int J Pharm 80: 511-62
103. Nanjwade B, Patel DJ, Udhani R, Manvi F. (2011). Functions of lipids for enhancement of oral bioavailability of poorly water-soluble drugs. Sci Pharm 879: 705-27
104. Nazzal S, Khan MA. (2006). Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters. Int J Pharm 315: 110-21
105. Nekkanti VK, Karatg PK, Prabhu R, Pilai R. (2010). Solid self-microemulsifying formulation of candesartan cilexetil. AAPS PharmSciTech 2: 9-17
106. Nicolaides E, Symillides M, Dressman JB, Reppas C. (2001). Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration. Pharm Res 18: 380-8
107. Nune SK, Gunda P, Majeti BK, et al. (2011). Advances in lymphatic imaging and drug delivery. Adv Drug Deliv Rev 63: 876-85
108. Oussoren C, Storm G. (2011). Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev 50: 143-56
109. Oussoren C, Zuidema J, Crommelin DJA, Storm G. (1997). Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid composition and lipid dose. Biochim Biophys Acta 1328: 261-72
110. Park SH, Choi KH. (2006). The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs. Int J Pharm 321: 35-41
111. Parmar N, Singla N, Amina S, Kohli K. (2011). Study of co-surfactant effect on nano emulsifying area and development of lercanidipine loaded (SNEDDS) self nanoemulsifying drug delivery system. Colloids Surf B 86: 327-38
112. Patel K, Kearney AS, Palepu NR. (1997). Investigation of new degradation products arising from the encapsulation of an oilbased suspension formulation of topotecan. Int J Pharm 151: 7-13
113. Patil P, Patil V, Paradkar A. (2007). Formulation of a self-emulsifying system for oral delivery of simvastatin: in vitro and in vivo evaluation. Acta Pharm 57: 111-22
114. Plaizier-Vercammen JA, De Nève RE. (1981). Interaction of povidone with aromatic compounds II: evaluation of ionic strength, buffer concentration, temperature, and pH by factorial analysis. J Pharm Sci 70: 1252-6
115. Porter CJH, Charman WN. (2001). Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev 50: 61-80
116. Porter CJH, Pouton CW, Culine JF, Charman WN. (2008). Enhancing intestinal drug solubilisation using lipid based drug delivery systems. Adv Drug Deliv Rev 60: 673-91
117. Porter CJH, Trevaskis NL, Charman WN. (2007). Lipids and lipid based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 6: 231-8
118. Pouton CW. (2000). Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems. Eur J Pharm Sci 11: S93-8
119. Pouton CW. (2006). Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 29: 278-87
120. Pund S, Borade G, Rasve G. (2013). Improvement of anti-inflammatory and anti-angiogenic activity ofberberine by novel rapid dissolving nanoemulsifying technique. Phytomedicine : 10.1016/j.phymed.2013.09.013. [Epub ahead of print]
121. Pund S, Shete Y, Jagdale S. (2014). Multivariate analysis of physicochemical characteristics of lipid based nanoemulsifying cilostazol-quality by design. Colloids Surf B Biointerfaces 115: 29-36
122. Rahman A, Hussain A, Hussain S, et al. (2012). Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS). Drug Dev Ind Pharm 39: 1-19
123. Rane SS, Anderson BD. (2008). What determines drug solubility in lipid vehicles: is it predictable? Adv Drug Deliv Rev 60: 638-56
124. Rao J, McClements DJ. (2012). Food-grade microemulsions and nanoemulsions: role of oil phase composition on formation and stability. Food Hydrocolloids 29: 326-34
125. Reich VG. (1995). Effect of drying conditions on structure and properties of gelatin capsules: studies with gelatin films. Pharm Ind 57: 63-7
126. Rodriguez-Hornedo N, Murphy D. (1999). Significance of controlling crystallization mechanisms and kinetics in pharmaceutical systems. J Pharm Sci 88: 651-60
127. Roy A, Winnike R, Long S, et al. (2001). Development of a soft gelatin capsule formulation of a poorly soluble compound X using a selfemulsifying delivery system. In: Saint-Priest BT, ed. Oral drug absorption: a renaissance. Cedex, France: Gattefosse Corporation, 141-9
128. Sander C, Holm P. (2009). Porous magnesium aluminometasilicate tablets as carrier of a cyclosporine self-emulsifying formulation. AAPS PharmSciTech 10: 1388-95
129. Sato K. (2001). Crystallization behaviour of fats and lipids-A review. Chem Eng Sci 56: 2255-65
130. Schaich KM, Shahidi F, Zhong Y, Eskin NAM. (2013). Lipid oxidation. In: Eskin NAM, Shahidi F., eds. Biochemistry of foods, vol. 3. New York: Elsevier, 419-78
131. Seager H. (1985). Soft gelatin capsules: a solution to many tableting problems. Pharm Technol 9: 84-104
132. Serajuddin ATM, Sheen PC, Augustine MA. (1986). Water migration from soft gelatin capsule shell to fill material and its effect on drug solubility. J Pharm Sci 75: 62-4
133. Shah NH, Stiel D, Infeld MH, et al. (1992). Elasticity of soft gelatin capsules containing polyethylene glycol 400-quantitation and resolution. Pharm Technol 3: 126-31
134. Shahba AAW, Mohsin K, Alanazi FK. (2012). The studies of phase equilibria and efficiency assessment for self-emulsifying lipid-based formulation. AAPS PharmSciTech 13: 522-33
135. Solans C, Izquierdo P, Nolla J, et al. (2005). Nano-emulsions. Curr Opin Colloid Interface Sci 10: 102-10
136. Soukharev AR. (2007). Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev 59: 411-8
137. Sheehan JC, Hlavka JJ. (1957). The cross-linking of gelatin using a water-soluble carbodiimide. J Am Chem Soc 79: 4528-9
138. Siepmann J, Siepmann F. (2013). Mathematical modeling of drug dissolution. Int J Pharm 453: 12-24
139. Singh AK, Chaurasiya A, Singh M, et al. (2008). Exemestane loaded self-microemulsifying drug delivery system (SMEDDS) development and optimization. AAPS PharmSciTech 9: 628-34
140. Singh B, Bandopadhyay S, Kapul R, et al. (2009a). Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Expert Opin Drug Deliv 26: 427-1
141. Singh SK, Verma PRP, Razdan B. (2009b). Development and characterization of a carvedilol-loaded self-microemulsifying delivery system. Clin Res Regul Aff 26: 50-64
142. Sirois P. (2007). Feasibility assessment and considerations for scaling initial prototype lipid-based formulations to phase I/II clinical trial batches. In: Hauss DJ, ed. Oral lipid-based formulations enhancing the bioavailability of poorly water-soluble drugs, vol. 170. New York: Informa Healthcare, 63-77
143. Taha E, Ghorab D, Zaghloul AA. (2007). Bioavailability assessment of vitamin a self-nanoemulsified drug delivery systems in rats: a comparative study. Med Princ Pract 16: 355-9
144. Tang B, Cheng G, Gu JC, Xu CH. (2008). Development of solid self emulsifying drug delivery system; preparation techniques and dosage forms. Drug Discov Today 13: 606-12
145. Tang JL, Sun J, Guihe Z. (2007). Self-emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drug. Curr Drug Ther 2: 85-93
146. Thomas N, Mullertz A, Graf A, Rades T. (2012). Influence of lipid composition and drug load on the in vitro performance of self-nanoemulsifying drug delivery systems. J Phar Sci 101: 1721-31
147. Tilcock PSC. (1986). Lipid polymorphism. Chem Phys Lipid 40: 109-25
148. Tomihata K, Ikada Y. (1996). Cross-linking of gelatin with carbodiimides. Tissue Eng 2: 307-13
149. Trevaskis NL, Charman WN, Porter CJH. (2008). Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update. Adv Drug Deliv Rev 60: 702-16
150. Vardakou M, Mercuri A, Naylor TA, et al. (2011). Predicting the human in vivo performance of different oral capsule shell types using a novel in vitro dynamic gastric model. Int J Pharm 419: 192-9
151. Venkatesh G, Majid MIA, Mansor SM, et al. (2010). In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone. Drug Dev Ind Pharm 36: 735-43
152. Wadhwa J, Nair A, Kumria R. (2012). Emulsion forming drug delivery system for lipophilic drugs. Acta Pol Pharm Drug Res 69: 179-91
153. Wang Z, Sun J, Wang Y, et al. (2010). Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int J Pharm 38: 1-6
154. Warren DB, Benameur H, Porter CJH, Pouton CV. (2010). Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility. J Drug Target 18: 704-31
155. Wasylaschuk WR, Harmon PA, Wagner G, et al. (2007). Evaluation of hydroperoxides in common pharmaceutical excipients. J Pharm Sci 96: 106-16
156. Waters EA, Wickline SA. (2008). Contrast agents for MRI. Basic Res Cardiol 103: 114-21
157. Wei Y, Ye X, Shang X, et al. (2012). Enhanced oral bioavailability of silybin by a supersaturatable self-emulsifying drug delivery system (S-SEDDS). Colloids Surf A Physicochem Eng Aspects 396: 22-8
158. Welz MM, Ofner CM. (1992). Examination of self-crosslinked gelatin as a hydrogel for controlled release. J Pharm Sci 81: 85-90
159. Woo JS, Song YK, Hong JY, et al. (2008). Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers. Eur J Pharm Sci 33: 59-65
160. Xi J, Chang CK, Meng ZY, et al. (2009). Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid. AAPS PharmSciTech 10: 172-82
161. Xu S, Dai, WG. (2013). Drug precipitation inhibitors in supersaturable formulations. Int J Pharm 453: 36-43
162. Yanez JA, Wang S, Knemeyer IW, Wirth MA. (2011). Intestinal lymphatic transport for drug delivery. Adv Drug Deliv Rev 63: 923-42
163. Yang S, Gursoy N, Lambert G, Benita S. (2004). Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors. Pharm Res 21: 261-70
164. Yannas IV, Tobolsky AV. (1967). Cross-linking of gelatine by dehydration. Nature 215: 9-10
165. Yao G, Li Y. (2010). Preparation, characterization and evaluation of self-microemulsifying drug delivery systems (SMEDDSs) of Ligusticum chuanxiong oil. Biomed. Prev Nutr 1 (1): 36-42
166. Yi X, Wan J, Xu H, Yang X. (2008). A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs. Eur J Pharm Biopharm 70: 439-44
167. You J, Cui FD, Li QP. (2005). A novel formulation design about water-insoluble oily drug: preparation of zedoary turmeric oil microspheres with self-emulsifying ability and evaluation in rabbits. Int J Pharm 288: 315-23
168. Zhang P, Liu Y, Xu J. (2008). Preparation and evaluation of self-emulsifying drug delivery system of oridonin. Int J Pharm 355: 269-76
169. Zhu X, Schaich KM, Chen X, et al. (2012). Target release rate of antioxidants to extend induction period of lipid oxidation. Food Res Int 47: 1-5
170. Zidan AS, Sammour OA, Hammad MA, et al. (2007). Quality by design: understanding the product variability of a self-nanoemulsified drug delivery system of cyclosporine A. J Pharm Sci 96: 2409-23